Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 411

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 411
---
 |     1,709,000 |     |     |   |        50,000 |     |     |   |        120,000 |     |
| Option pricing models used               |     |   | Black-Scholes |     |     |   | Black-Scholes |     |     |   |  Black-Scholes |     |
| Share price                              |     | £ |        0.2775 | *   |     | £ |         0.265 | *   |     | £ |          0.255 | *   |
| Exercise price of options issued in year |     | £ |        0.2775 |     |     | £ |         0.265 |     |     | £ |          0.255 |     |
| Contractual life                         |     |   |      10 years |     |     |   |      10 years |     |     |   |       10 years |     |
| Expected life                            |     |   |       5 years |     |     |   |       5 years |     |     |   |        5 years |     |
| Volatility                               |     |   |         88.63 | %** |     |   |         88.59 | %** |     |   |          88.11 | %** |
| Expected dividend yield                  |     |   |             0 | %   |     |   |             0 | %   |     |   |              0 | %   |
| Risk free rate                           |     |   |          0.38 | %   |     |   |          0.26 | %   |     |   |           0.32 | %   |

| * | The share price used in the determination of the fair value of the options granted in 2021 was the share price on the date of grant. |

All other share options
relate to the Biodexa Limited 2008 unapproved share option scheme.

Share Incentive
Plan

In April 2017 the Group
set up the Biodexa Pharmaceuticals Share Incentive Plan (MPSIP). Under the BPSIP, Group employees and Directors can acquire ordinary shares
in the Company via a salary sacrifice arrangement. Biodexa grants matching shares for every share bought. In order to retain these shares,
scheme participants must remain employed by the Group